# Surgical Debulking of Pituitary Adenomas

> **NCT01371643** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 41 (actual)

## Conditions studied

- Pituitary Adenoma

## Interventions

- **DRUG:** Octreotide LAR
- **PROCEDURE:** transsphenoidal surgery

## Key facts

- **NCT ID:** NCT01371643
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2010-07
- **Final completion:** 2011-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371643, "Surgical Debulking of Pituitary Adenomas". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01371643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*